2 results
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Alectinib versus ... Lung Cancer #EBM #Honc ... Crizotinib #ALK #ALKPositive ... VisualAbstract #NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Adjuvant Nivolumab versus ... Ipilimumab in Resected ... Population #EBM #Honc ... #Nivolumab #Ipilimumab ... #Melanoma #NEJM